| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776074 | Urology | 2018 | 24 Pages |
Abstract
p38 MAPK is a potential therapeutic target in bladder cancer and this strategy warrants further development in this disease. It may also allow combination therapy strategies to be developed in conjunction with EGFR or HER2 inhibition.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Regina Mora Vidal, Sergio Regufe da Mota, Annette Hayden, Hannah Markham, James Douglas, Graham Packham, Simon J. Crabb,